Tag:

Dr. Scott Gottlieb

COVID-19: Subvariant XBB Accounts For 70% Of Tristate NY Cases, Sparking Concerns Of New Wave COVID-19: Subvariant XBB Accounts For 70% Of Tristate NY Cases, Sparking Concerns Of New Wave
Covid-19: Subvariant XBB Accounts For 70% Of Tristate NY Cases, Sparking Concerns Of New Wave An Omicron strain called XBB.1.5 which now accounts for the majority of COVID-19 cases from the New York tristate area through New England has the potential to trigger a new wave of infections, a top expert is now saying. The XBB.1.5 variant makes up 40.5 percent of cases in the United States, and 70 percent of cases in the New York tristate area through New England, according to the Centers for Disease Control and Prevention (CDC). "I would expect a wave of infection with this new variant," Dr. Scott Gottlieb, former commissioner of the Food and Drug Administration (FDA), told MS…
COVID-19: US Sees Record 1.35M Cases In A Day, But Expert Says That Doesn't Tell Whole Story COVID-19: US Sees Record 1.35M Cases In A Day, But Expert Says That Doesn't Tell Whole Story
Covid-19: US Sees Record 1.35M Cases In A Day, But Expert Says That Doesn't Tell Whole Story Fueled by the highly contagious Omicron variant, the United States reported a record-breaking 1.35 million COVID-19 infections in a day on Monday, Jan. 10.  But that may not even be close to the actual number of cases. "We're probably only diagnosing somewhere between one in five and one in 10 actual infections," Former FDA Commissioner Dr. Scott Gottlieb said Sunday, Jan. 9 on CBS-TV. Gottlieb added that there are "probably a lot of people walking around with asymptomatic infection who don't know it, but are spreading it." That scenario could cause staffing issues for hospitals, and…
COVID-19: Wave Of Omicron Cases In US May Be At Turning Point, Virus Expert Says COVID-19: Wave Of Omicron Cases In US May Be At Turning Point, Virus Expert Says
Covid-19: Wave Of Omicron Cases In US May Be At Turning Point, Virus Expert Says The wave of COVID-19 cases in the United States triggered by the highly contagious Omicron variant may be at a turning point, an infectious disease expert says. Former FDA commissioner Dr. Scott Gottlieb says parts of the nation may be about to pass the peak phase of the outbreak, while other regions will likely soon be hit hard. "f you look what's happening across the East Coast right now in New York City, Washington, DC, Maryland, probably Florida as well have already peaked, maybe Delaware and Rhode Island," Gottlieb said Sunday, Jan. 9 on CBS-TV's "Face the Nation." "You start to see t…
COVID-19: True Delta Wave Has Not Yet Hit Northeast, Former FDA Commissioner Says COVID-19: True Delta Wave Has Not Yet Hit Northeast, Former FDA Commissioner Says
Covid-19: True Delta Wave Has Not Yet Hit Northeast, Former FDA Commissioner Says The "true delta wave" has not hit the Northeast yet, and it will arrive sometime after Labor Day weekend, former United States Food and Drug Administration Commissioner Dr. Scott Gottlieb said. Gottlieb said in an interview with CNBC on Friday, Sept. 3, that he thinks the jump in delta variant cases in the Northeast that has since decreased was a warning for another spike in cases that will hit the region. He predicted that gatherings during Labor Day weekend and children returning to school will lead to cases increasing once again. Gottlieb recommended that schools increase the frequency …
COVID-19: Here's When Vaccine Rollout May Start For Kids Ages 5 To 11 COVID-19: Here's When Vaccine Rollout May Start For Kids Ages 5 To 11
Covid-19: Here's When Vaccine Rollout May Start For Kids Ages 5 To 11 The Pfizer COVID-19 vaccine could be available to children ages 5 and older late in the fall or early this winter, according to a company board member. Former Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb told CNBC that he believes the company's COVID vaccine will be approved for emergency use for children ages 5 to 11 sometime this fall or winter. Gottlieb told the news outlet that the application will likely be submitted to the FDA in October.  He said the FDA will likely take four-to-six weeks to review the application, so the emergency use authorization c…
COVID-19: There Could Be Some Long-Term Loss Of Brain Tissue From Virus, New Study Says COVID-19: There Could Be Some Long-Term Loss Of Brain Tissue From Virus, New Study Says
Covid-19: There Could Be Some Long-Term Loss Of Brain Tissue From Virus, New Study Says There could be some long-term loss of brain tissue from COVID-19 that would have some lingering consequences, according to a brand-new study. That loss of brain tissue may explain why COVID patients lost their sense of smell, according to the study, which was conducted in the United Kingdom. "They looked at people who had had MRI scans of their brains in the past three years and they looked at how many developed COVID and about 300 people, a little over 300 people developed COVID," said former Food and Drug Administration Director Dr. Scott Gottlieb on CBS-TV's "Face the Nation" on Sunday, …
COVID-19: Delta Variant's Symptoms Different, More Dangerous Than Original Virus, Doctors Say COVID-19: Delta Variant's Symptoms Different, More Dangerous Than Original Virus, Doctors Say
Covid-19: Delta Variant's Symptoms Different, More Dangerous Than Original Virus, Doctors Say The Delta variant of COVID-19, by far the most contagious strain during the entire pandemic, has different and more dangerous symptoms than the original virus, doctors are now warning. The strain, first detected in India in December 2020, now makes up 90 percent of new cases in the United Kingdom and 10 percent of new cases in the United States. Doctors in China told state-run television that their patients who have the Delta strain, known as B.1.617.2, are becoming sicker and their conditions are worsening at a faster rate, according to The New York Times. Around 12 percent of Delta varia…
COVID-19: Fourth Wave? Experts Disagree, But Say US At Tipping Point In Battle Vs. Virus COVID-19: Fourth Wave? Experts Disagree, But Say US At Tipping Point In Battle Vs. Virus
Covid-19: Fourth Wave? Experts Disagree, But Say US At Tipping Point In Battle Vs. Virus Who will win - the vaccine or the variants? That appears to be the question as to whether or not the United States could see a potential fourth wave of cases amid the COVID-19 pandemic. Two of the nation's top experts disagree but both are saying America is at a tipping point in the now more than one-year-long war against the virus.  Here's how it stands as of Monday, April 5.  More than one-third of American adults have received at least one dose of the vaccine. At the same time, there have been outbreaks of cases, especially in younger people, of the more contagious B.1.1.7 st…